Table 1.
Clinical Features | GFAP-IgG | CRMP5-IgG | CRION | Sarcoidosis | Optic Perineuritis |
---|---|---|---|---|---|
Sex distribution | F:M 1:1 [15] | F:M 1:1 [28] | F:M 2:1 [66] | F:M 1:1 [78] | 2.5:1 [63] |
Age at onset (median/mean) | 44–50 years | 69 years | 35.7 years | 42–48 years | 41 years |
Retro-orbital pain | Rare | Rare | Prominent | Frequent | Prominent |
Visual loss severity | (1) No HCVA loss (bilateral optic disc edema) or (2) severe bilateral vision loss | Variable, median around 20/40 | Severe: 20/200 in two-thirds of cases | Severe; often NLP | Mild, often central vision sparing |
Optic disc edema | Very frequent; may be asymptomatic | Very frequent | Variable | Variable | Frequent |
Visual loss course | Subacute | Subacute | Subacute | Subacute to slowly progressive | Subacute to slowly progressive |
MRI findings | Symmetrical FLAIR hyperintensities involving basal ganglia, thalami, internal, and external capsules; Linea radial (or leptomeningeal) contrast enhancement | Optic nerve may be normal; rarely T2 hyperintensities with no Gd enhancement; brain MRI can show basal ganglia, medial temporal lobe, extensive white matter, hippocampus, cerebellum, insula, thalamus, and frontal lobe T2 hyperintensities | Normal in 40% of patients; possibly isolated T2 hyperintense lesions in periventricular or juxtacortical white matter | Leptomeningeal or pachymeningeal enhancement, including cranial nerve enhancement, MS-like white matter lesions, optic nerve T2 hyperintensities, focal parenchymal areas of contrast enhancement | Ill-defined, circumferential optic nerve sheath enhancement (“tramtrack” or “doughnut” sign) to be differentiated from optic nerve sheath meningioma, orbital pseudotumor, or sarcoidosis; possible enhancement of orbital fat surrounding optic nerve sheath or extraocular muscle |
OCT findings | In cases of optic disc edema: normal outer retina with elevated retinal nerve fiber layer thickness [20] |
Increased RNFL consistent with optic disc edema (acute phase); atrophy of the outer retinal layers was noted, with deepening of the foveal depression; hyperreflective dots (atrophic stage) [79,80] | Severe thinning in RNFL and thinning in intra-retinal segments of IPL, GCL, RNFL, and TMV compared with NMOSD and MS-related ON [81] |
Subretinal fluid, macular edema, and loss of retinal architecture; no alterations in patients without clinical optic involvement [82] | Significant thinning of average peripapillary RNFL [83] |
Steroid dependency | Limited | None | Severe | Severe | Severe |